Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions

Cited by (1,000)

Items 601–700 of 1,000

1. Inflammatory Mediators and GBM Malignancy: Current Scenario and Future Prospective
   Ilya V. Ulasov, Vaishali Singh, Anastasia Laevskaya, Peter S. Timashev, Rajesh Kumar Kharwar · 2023 · Discovery Medicine
2. The MANGO study: a prospective investigation of oxygen enhanced and blood-oxygen level dependent MRI as imaging biomarkers of hypoxia in glioblastoma
   Caterina Brighi, David E. J. Waddington, Paul Keall, Jeremy Booth, Kieran O’Brien, Shona Silvester, Jonathon Parkinson, Marco Mueller, Jackie Yim, Dale L. Bailey et al. · 2023 · Frontiers in Oncology
3. Epigenetic modification and characterization of the MGMT promoter region using CRISPRoff in glioblastoma cells
   Remi Weber, Michael Weller, Guido Reifenberger, Flavio Vasella · 2024 · Frontiers in Oncology
4. Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 1. Brain and head and neck
   Soo‐Yoon Sung, Jin Ho Song, Byoung Hyuck Kim, Yoo-Kang Kwak, Kyung Su Kim, Gyu Sang Yoo, Hwa Kyung Byun, Yeon Joo Kim, Yeon‐Sil Kim · 2024 · Radiation Oncology Journal
5. Cost-effectiveness analysis of bevacizumab combined with lomustine in the treatment of progressive glioblastoma using a Markov model simulation analysis
   Zhaoyan Chen, Fangyuan Tian, Ying Zhang · 2024 · Frontiers in Public Health
6. Challenges and opportunities in newly diagnosed glioblastoma in the United Kingdom: A Delphi panel
   Helen Bulbeck, Karen E. Noble, Kathy Rose Oliver, Tina Mitchell Skinner · 2024 · Neuro-Oncology Practice
7. Velcrin molecular glues induce apoptosis in glioblastomas with high PDE3A and SLFN12 expression
   Elisa Aquilanti, Silvia Goldoni, Andrew Baker, Kristýna Kotýnková, Sawyer Andersen, Vincent Bozinov, Galen F. Gao, Andrew D. Cherniack, Martin Lange, Ralf Lesche et al. · 2024 · Neuro-Oncology Advances
8. Biopsy location and tumor-associated macrophages in predicting malignant glioma recurrence using an in-silico model
   Pejman Shojaee, Edwin Weinholtz, Nadine S. Schaadt, Friedrich Feuerhake, Haralampos Hatzikirou · 2025 · npj Systems Biology and Applications
9. Green chemistry: Modern therapies using nanocarriers for treating rare brain cancer metastasis from colon cancer
   Doaa S. R. Khafaga, Ghazala Muteeb, Darin W Aswa, Mohammad Aatif, Mohd Farhan, Salma Allam · 2025 · SLAS DISCOVERY
10. Anatomical distribution and prognostic heterogeneity in glioma: unique clinical features of occipital glioblastoma
    Chongshun Zhao, Bo Liang, Xiaopeng Li, Peiheng Ma, Yiming Li, Zenghui Qian, Zhong Zhang, Tao Jiang, Wei Zhang · 2025 · Journal of Neuro-Oncology
11. Repeatability of radiotherapy dose-painting prescriptions derived from a multiparametric magnetic resonance imaging model of glioblastoma infiltration
    Caterina Brighi, Niels Verburg, Eng‐Siew Koh, Amy Walker, Cathy Chen, Sugendran Pillay, Philip C. De Witt Hamer, Farhannah Aly, Lois Charlotte Holloway, Paul Keall et al. · 2022 · Physics and Imaging in Radiation Oncology
12. Noninvasive Evaluation of the Notch Signaling Pathway via Radiomic Signatures Based on Multiparametric MRI in Association With Biological Functions of Patients With Glioma: A Multi‐institutional Study
    Nanxi Shen, Wenzhi Lv, Shangyu Li, Dong Liu, Yan Hong Xie, Ju Zhang, Jiaxuan Zhang, Jingjing Jiang, Rifeng Jiang, Wenzhen Zhu · 2022 · Journal of Magnetic Resonance Imaging
13. Differential roles of type I interferon signaling in tumor versus host cells in experimental glioma models
    Evelina Blomberg, Manuela Silginer, Patrick Roth, Michael Weller · 2022 · Translational Oncology
14. The role of cytoreductive surgery in multifocal/multicentric glioblastomas
    Diyan Dimov, Daniel Brainman, Björn Berger, Roland Coras, Alexander Grote, Matthias Simon · 2023 · Journal of Neuro-Oncology
15. NFYB increases chemosensitivity in glioblastoma by promoting HDAC5-mediated transcriptional inhibition of SHMT2
    Yingfan Zhang, Haoxuan Huang, Peikun Liu, Yuanyang Xie · 2023 · Journal of Neuropathology & Experimental Neurology
16. Anti-Glioma Effects of Ligustilide or n-Butylphthalide on Their Own and the Synergistic Effects with Temozolomide via PI3K/Akt Signaling Pathway
    Ziqi Li, Guosong Zhang, Ri-qun Liu, Shuyuan Shuai, Peng-yi Hu, Qin Zheng, Shu-Hua Xiao · 2023 · OncoTargets and Therapy
17. Adult neuro-oncology trials in the United States over 5 decades: Analysis of trials completion rate to guide the path forward
    Emily J. Smith, Anant Naik, Mahima Goel, Patrick Yung Wen, Michael K. Lim, Susan Marina Chang, Isabelle M. Germano · 2024 · Neuro-Oncology Advances
18. Impact of tissue-agnostic approvals on management of primary brain tumors
    Manmeet Singh Ahluwalia, Atulya Aman Khosla, Ahmad Ozair, Mohamed Alaa Gouda, Vivek Subbiah · 2024 · Trends in cancer
19. Antiangiogenic exclusion rules in glioma trials: Historical perspectives and guidance for future trial design
    Ugur T. Sener, Mahnoor Islam, Mason Webb, Sani Haider Kizilbash · 2024 · Neuro-Oncology Advances
20. A Biopsy-Controlled Prospective Study of Contrast-Enhancing Diffuse Glioma Infiltration Based on FET-PET and FLAIR
    Maciej Harat, Izabela Miechowicz, Józefina Rakowska, Izabela Zarębska, Bogdan Małkowski · 2024 · Cancers
21. Genomics and proteomics to determine novel molecular subtypes and predict the response to immunotherapy and the effect of bevacizumab in glioblastoma
    Dongdong Luo, Aiping Luo, Su Hu, Ganwei Ye, Dan Li, Hailin Zhao, Biao Peng · 2024 · Scientific Reports
22. Impact of anesthesia and analgesia techniques on glioblastoma progression. A narrative review
    Ann Privorotskiy, Shreyas P. Bhavsar, Frederick F. Lang, JIAN LI HU, Juan Pablo Cata · 2020 · Neuro-Oncology Advances
23. Association of XRCC3 rs1799794 polymorphism with survival of glioblastoma multiforme patients treated with combined radio-chemotherapy
    Francesco Pasqualetti, Alessandra Gonnelli, Paola Orlandi, Eleonora Palladino, Noemi Giannini, Giovanni Gadducci, Roberto Mattioni, SABRINA MONTRONE, Elisa Calistri, Chiara Maria Mazzanti et al. · 2021 · Investigational New Drugs
24. Early 2 factor (E2F) transcription factors contribute to malignant progression and have clinical prognostic value in lower-grade glioma
    Haitao Luo, Chuming Tao, Xiaoyan Long, Xingen Zhu, Kai Huang · 2021 · Bioengineered
25. Development and validation of a novel survival prediction model for newly diagnosed lower-grade gliomas
    Qiang Zhu, Yuchao Liang, Ziwen Fan, Yukun Liu, Chunyao Zhou, Hong Zhang, Lei He, Tianshi Li, Jianing Yang, Yanpeng Zhou et al. · 2022 · Neurosurgical FOCUS
26. Validation Study for Non-Invasive Prediction of IDH Mutation Status in Patients with Glioma Using In Vivo 1H-Magnetic Resonance Spectroscopy and Machine Learning
    Elisabeth Bumes, Claudia Fellner, Franz A. Fellner, Karin Fleischanderl, Martina Häckl, Stefan Lenz, Ralf Andreas Linker, Tim Mirus, Peter Josef Oefner, Christian Paar et al. · 2022 · Cancers
27. Integrated bioinformatics analysis and experimental validation reveal ISG20 as a novel prognostic indicator expressed on M2 macrophage in glioma
    Yaojun Peng, Hongyu Liu, Qiyan Wu, Lingxiong Wang, Yanju Yu, Fan Yin, Cong Feng, Xuewen Ren, Tianyi Liu, Ling Chen et al. · 2023 · BMC Cancer
28. International Financial Institutions Face the Corruption Eruption: If the IFIs put Their Muscle and Money Where Their Mouth is, the Corruption Eruption May be Capped
    James P. Wesberry · 1997 · bepress Legal Repository
29. Human Organoid Tumor Transplantation Identifies Functional Glioblastoma - Microenvironmental Communication Mediated by PTPRZ1
    Weihong Ge, Ryan L. Kan, Can Yilgor, Elisa Fazzari, Patricia R. Nano, Daria J. Azizad, Matthew X. Li, Joyce Y. Ito, Christopher Tse, Hong A. Tum et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
30. VCAN in the extracellular matrix drives glioma recurrence by enhancing cell proliferation and migration
    Ruolun Wei, Haoyun Xie, Yukun Zhou, Xuhao Chen, Liwei Zhang, Brandon Bui, Xianzhi Liu · 2024 · Frontiers in Neuroscience
31. A Multicenter Study on Intraoperative Glioma Grading via Deep Learning on Cryosection Pathology
    Xi Liu, Tianyang Sun, Hong Chen, Shuai Wu, Haixia Cheng, Xiaojia Liu, Qi Lai, Kun Wang, Lin Chen, Junfeng Lu et al. · 2025 · Modern Pathology
32. Advancements in nanotechnology-based targeted drug delivery systems for glioblastoma chemotherapy: A comprehensive review
    Upmaniu Gupta, Sourabh Kosey, Rahul Pal · 2025 · Journal of Drug Delivery Science and Technology
33. Integration of omics data in the diagnosis and therapy of glioblastoma
    Constantin Möller, Melanie Schoof, Keith Lloyd Ligon, Ulrich Schüller · 2025 · Brain Pathology
34. Revisiting an old therapy for new, promising combinations: Biology and perspectives of lomustine in glioma treatment
    Charlotte Bellamy, Cynthia Hajal, Keith Lloyd Ligon, Mehdi Touat · 2025 · Neuro-Oncology
35. Preventing Glioblastoma Relapse by Igniting Innate Immunity through Mitochondrial Stress in the Surgical Cavity
    Xu Han, Fan Feng, Zixu Wang, Shujun Huang, Kaiyan Xi, Zezheng Fang, Jianyu Shen, Mingrui Wang, Yi Zhang, Ben Liu et al. · 2025 · Advanced Materials
36. Innovative aptamer approaches in glial tumor diagnostics and therapy: Progress and future directions
    Natalia A. Luzan, Tatiana N. Zamay, Penghui Zhang, Народов Андрей Аркадьевич, Замай Галина Сергеевна, Anna S. Kichkailo, Maxim V. Berezovski, Olga S. Kolovskaya · 2025 · Molecular Therapy — Nucleic Acids
37. HRH1-targeting mAb: a precision therapeutic strategy for Glioblastoma
    Kankai Wang, Peiqi Zhao, Xiaohong Zhu, Fan Tang, Hong Chen, Ying Zhang, Hao Wang, Yu Chen, Yuan‐Bo Pan, Qichuan Zhuge et al. · 2025 · Oncogene
38. Design and Targeting Strategies in Nanotheranostics for Glioma
    Chenghui Zheng, Runge Zhao, Jiaxin Wang, Mengjie Dong, Zhao Yong-sheng, Jing Mu · 2025 · ACS Nano Medicine
39. Longitudinal, label-free, high-resolution imaging of glioblastoma spheroid response to therapy: a translational tool for preclinical evaluation of chemotherapy, radiation, and immunotherapy
    Caroline E. Serafini, Amin Davarzani, Dan Cappabianca, Zhenmin Li, Daniela Baez Collazos, Deniz Mamaghani, Leidong Mao, Krishanu Saha, Lohitash Karumbaiah, Francisco E. Robles · 2025 · Optica
40. A comprehensive framework for glioma surgery by the PIONEER Consortium and RANO resect group, part 2: perioperative recommendations for neurological, language, functional, and quality-of-life assessment
    Jasper K W Gerritsen, Philipp Karschnia, Lorenzo Bello, Shawn L. Hervey‐Jumper, Jacob S. Young, Kathleen Seidel, Djaina Satoer, Oliver Schnell, Michael Parsons, Brian Vala Nahed et al. · 2025 · The Lancet Oncology
41. Unraveling the glioblastoma (GBM) tumor microenvironment: future perspective on targeted immunotherapy
    Jia Li, Abdulkareem Qasem Moqbel, Yongzhao Wang, Erhu Zhao, Muhammad Usman Ghani, Ping Liang · 2026 · Biochemical Pharmacology
42. Surface-engineered dual drug-loaded tumor-targeted liposomal nanoparticles to overcome the therapeutic resistance in glioblastoma multiforme
    Ramcharan Singh Angom, Hari Krishnareddy Rachamala, Naga Malleswara Rao Nakka, Vijay Sagar Madamsetty, Paola Suárez-Meade, Beatriz I. Fernández-Gil, Tanmay Kulkarni, Raegan M. Weil, Shamit Kumar Dutta, Enfeng Wang et al. · 2026 · Communications Medicine
43. Exploring the potentials of S4, a selective androgen receptor modulator, in glioblastoma multiforme therapy
    Mervenur Yavuz, Turan Demircan · 2024 · Toxicology and Applied Pharmacology
44. Photodynamic therapy with curcumin and near-infrared radiation as an antitumor strategy to glioblastoma cells
    Marcelo Augusto Germani Marinho, Magno da Silva Marques, Camila de Oliveira Vian, Daza de Moraes Vaz Batista Filgueira, Ana Paula Horn · 2024 · Toxicology in Vitro
45. Abnormal Vessels Potentially Accelerate Glioblastoma Proliferation by Inducing the Protumor Activation of Macrophages
    Hiroaki Matsuzaki, Keitaro Kai, Yoshihiro Komohara, Hiromu Yano, Cheng Pan, Yukio Fujiwara, Rin Yamada, Ai Iwauchi, Nei Fukasawa, Toshihide Tanaka et al. · 2025 · Cancer Science
46. Microfluidic approaches for liquid biopsy in glioblastoma: Insights into diagnostic and follow‐up strategies
    Clara Bayona, Teodora Ranđelović, Claudia Olaizola‐Rodrigo, Ignacio Ochoa · 2025 · Bioengineering & Translational Medicine
47. Acid-Sensing Ion Channel 1 Contributes to Weak Acid-Induced Migration of Human Malignant Glioma Cells
    Sareena Shah, Yuyang Chu, Victoria Cegielski, Xiang‐Ping Chu · 2021 · Frontiers in Physiology
48. The Evolution of Laser-Induced Thermal Therapy for the Treatment of Gliomas
    Purvee D. Patel, Nitesh V. Patel, Shabbar F. Danish · 2023 · Neurosurgery Clinics of North America
49. Frequency and Prognostic Relevance of Volumetric MRI Changes in Contrast- and Non-Contrast-Enhancing Tumor Compartments between Surgery and Radiotherapy of IDHwt Glioblastoma
    Nico Teske, Nina C. Teske, Maximilian Niyazi, Claus Belka, Niklas Thon, Joerg‐Christian Tonn, Robert Forbrig, Philipp Karschnia · 2023 · Cancers
50. Predicting the spatio-temporal response of recurrent glioblastoma treated with rhenium-186 labelled nanoliposomes
    Chase Christenson, Chengyue Wu, David A. Hormuth, Shi‐Liang Huang, Ande Bao, Andrew Jacob Brenner, Thomas E. Yankeelov · 2023 · Brain Multiphysics
51. Gene signatures associated with prognosis and chemotherapy resistance in glioblastoma treated with temozolomide
    Tonia Carter, Robert K. Valenzuela, Srinivasulu Yerukala Sathipati, Rafael Medina‐Flores · 2023 · Frontiers in Genetics
52. Optimizing Recurrent Glioblastoma Salvage Treatment: A Multicenter Study Integrating Genetic Biomarkers From the Korean Radiation Oncology Group (21-02)
    Dowook Kim, Joo Ho Lee, Nalee Kim, Do Hoon Lim, Jin Ho Song, Chang‐Ok Suh, Chan Woo Wee, In Ah Kim · 2024 · Neurosurgery
53. 11C-methionine in the diagnostics and management of glioblastoma patients with rapid early progression: nonrandomized, open label, prospective clinical trial (GlioMET)
    Radek Lakomý, Martina Lojová, Lenka Součková, Ludmila Hynková, Kateřina Procházková, Jiří Vašina, Regina Demlová, Alexandr Poprach, Jiří Šáňa, Tomáš Procházka et al. · 2024 · BMC Cancer
54. A multicenter, phase 1, Adult Brain Tumor Consortium trial of oral terameprocol for patients with recurrent high-grade glioma (GATOR)
    Manmeet Singh Ahluwalia, Ahmad Ozair, Michelle A. Rudek, Xiaobu Ye, Matthias Holdhoff, Frank Scott Lieberman, Anna F. Piotrowski, Burt Nabors, Arati Suvas Desai, Glenn Jay Lesser et al. · 2024 · Cell Reports Medicine
55. Current chemotherapy strategies for adults with IDH-wildtype glioblastoma
    Jing Bao, Rui Sun, Zhenjiang Pan, Shepeng Wei · 2024 · Frontiers in Oncology
56. Imaging timing after surgery for glioblastoma: an evaluation of practice in Great Britain and Ireland (INTERVAL-GB)- a multi-centre, cohort study
    INTERVAL-GB Collaborative, Conor Scott Gillespie, Emily Rose Bligh, Michael T. C. Poon, Abdurrahman I. Islim, Georgios Solomou, Melissa Gough, Christopher Paul Millward, Ola Rominiyi, Rasheed Zakaria et al. · 2024 · Journal of Neuro-Oncology
57. Neurosurgical Breakthroughs of the Last 50 Years: A Historical Journey Through the Past and Present
    Orlando De Jesús · 2025 · World Neurosurgery
58. Second-line temozolomide in first recurrent MGMT-methylated glioblastoma after lomustine/temozolomide: Efficacy and safety
    Thomas Zeyen, Antonia Treiber, Matthias B. Schneider, Anna‐Laura Potthoff, Christina Schaub, Lea Roever, Julian Philipp Layer, Eleni Gkika, Hartmut Vatter, Daniel Paech et al. · 2025 · Neuro-Oncology Advances
59. Surviving Over a Decade With Glioblastoma: A Clinical Course Characterized by Multiple Recurrences, Numerous Salvage Treatments, and Novel Use of Cesium-131 Tiles
    Shahil Mehta, April Vassantachart, Croix C. Fossum, Wensha Yang, Zhilei Liu Shen, Ki-Eun Chang, Jason C. Ye, Thomas C. Chen, Eric Lin Chang · 2021 · Cureus
60. First Report of Tumor Treating Fields (TTFields) Therapy for Glioblastoma in Comorbidity with Multiple Sclerosis
    Rebecca Kassubek, René Mathieu · 2022 · Brain Sciences
61. Natural killer cells in the treatment of glioblastoma: Diverse antitumor functions and potential clinical applications
    Barbara Breznik, Metka Novak, Bernarda Majc, Anamarija Habič, Anahid Jewett · 2023 · Elsevier eBooks
62. Refining the Intraoperative Identification of Suspected High-Grade Glioma Using a Surgical Fluorescence Biomarker: GALA BIDD Study Report
    Colin Watts, Alimu Dayimu, Tomasz Matys, Keyoumars Ashkan, Stephen John Price, Michael D. Jenkinson, Gail Doughton, Claire Mather, Gemma Young, Wendi Qian et al. · 2023 · Journal of Personalized Medicine
63. Temozolomide protects against the progression of glioblastoma via SOX4 downregulation by inhibiting the LINC00470‐mediated transcription factor EGR2
    Wenyang Li, Ming Wang, Wenjia Ma, Ping Liu, Mingming Zhang, Jiarong He, Yan Cui · 2023 · CNS Neuroscience & Therapeutics
64. Hsa_circITGA4/ miR-1468/EGFR/ PTEN a Master Regulators Axis in Glioblastoma Development and Progression
    Sara Tutunchi, Ahmad Bereimipour, Sayyed Mohammad Hossein Ghaderian · 2023 · Molecular Biotechnology
65. Investigating the effects of arginine methylation inhibitors on microdissected brain tumour biopsies maintained in a miniaturised perfusion system
    Antonia Barry, Sabrina Francesca Samuel, Inès Hosni, Amr Moursi, Lauric Feugere, Christopher Sennett, Srihari Deepak, Shailendra Achawal, Chittoor Rajaraman, Alexander Iles et al. · 2023 · Lab on a Chip
66. MGMT Promoter Methylation and Chemotherapy Outcomes in Low-Grade and Anaplastic Gliomas
    Binghao Zhao, Hao Qi, Wenbin Ma · 2023 · JAMA Oncology
67. Oncogenes and cancer associated thrombosis: what can we learn from single cell genomics about risks and mechanisms?
    Nadim Tawil, Abdulshakour Mohammadnia, Janusz W. Rak · 2023 · Frontiers in Medicine
68. Optimizing adjuvant treatment options for patients with glioblastoma
    Enzhao Zhu, Jiayi Wang, Weizhong Shi, Jing Qi, Pu Ai, Dan Shan, Zisheng Ai · 2024 · Frontiers in Neurology
69. Alkylating agents are possible inducers of glioblastoma and other brain tumors
    Carr J. Smith, Thomas A. Perfetti, Chirayu Chokshi, Chitra Venugopal, John Wesson Ashford, Sheila Kumari Singh · 2024 · Human & Experimental Toxicology
70. Is there an optimal MRI surveillance schedule for patients with high-grade glioma after standard-of-care-therapy?
    Mary Jane Lim-Fat, Pejman Jabehdar Maralani · 2021 · Neuro-Oncology
71. Cellular and molecular events organizing the assembly of tertiary lymphoid structures in glioblastoma
    Alessandra Vaccaro, Fan Yang, Tiarne van de Walle, Saskia Franke, Roberta Lugano, Anna Dénes, Anastasia Magoulopoulou, Inés Cid-Fariña, Anja Smits, Lene Uhrbom et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
72. Transcriptomics and epigenomics datasets of primary brain cancers in formalin-fixed paraffin embedded format
    Anabel García‐Heredia, Luna Guerra-Núñez, Paula Martín-Climent, Estefanía Rojas, Raúl López-Domínguez, Clara Alcántara-Domínguez, Cristina Alenda, Luis Miguel Valor · 2025 · Scientific Data
73. KCNE3 Facilitates M1 Macrophage Polarization by Suppressing the Wnt/β‐Catenin Pathway, Inhibiting Glioma Proliferation, Migration, and Invasion
    Shangyu Liu, Qiao Li, Liang Niu, Peng Feng, Wenshan Li, Ying Dang, Juan Jia, Guoqiang Yuan, Yawen Pan · 2025 · Molecular Carcinogenesis
74. MiR 329/449 Suppresses Cell Proliferation, Migration and Synergistically Sensitizes GBM to TMZ by Inhibiting Src/FAK, NF-kB, and Cyclin D1 Activity
    Megan Mendieta, Mehrdad Bandegi, Ezgi Biltekin, Yasemin M. Akay, Bulent Ozpolat, Metin Akay · 2025 · International Journal of Molecular Sciences
75. Glasdegib in combination with temozolomide and radiotherapy in adult patients with newly diagnosed glioblastoma: the phase Ib/II GEINO 1602 trial
    María Ángeles Vaz Salgado, Sonia Del Barco, Juan Manuel Sepúlveda-Sánchez, Miriam D. Alonso, Estela Pineda, Carmen Balañá, Maria Martinez‐García, Regina Gironés · 2025 · Nature Communications
76. Immunotherapy and targeted therapy for high grade gliomas: current and future directions
    Brian Hsueh, Samuel J. Steuart, Angel O. Odukoya, Briana C. Prager, Young Joon Kim, Cameron M. Hill, Bryan D. Choi, Gavin P. Dunn · 2025 · Journal of Neuro-Oncology
77. Targeting WTAP/ROR1/WNT5A‐Mediated Crosstalk Between Glioma Stem Cells and Macrophages to Normalize Tumor Vasculature and Enhance Chemotherapy
    Xiaoyong Chen, Bo Pang, Yun Liu, Jiangwei Wang, Lanhui Zheng, Yuzhou Chang, Yingxuan Sun, Haoyuan Sun, Huiyuan Chen, Jiawei Cai et al. · 2026 · Advanced Science
78. Nonconvulsive status epilepticus characteristics in glioma patients: a retrospective study
    Azumi Kaneoka, Satoka Hashimoto, Kaoru Tamura, Motoki Inaji, Taketoshi Maehara · 2023 · Discover Oncology
79. Long-read sequencing for brain tumors
    William Jeremy Shelton, Sara Zandpazandi, James Stephen Nix, Murat Gökden, Michael Bauer, Katie Rose Ryan, Christopher P. Wardell, Olena M. Vaske, Analiz Rodriguez · 2024 · Frontiers in Oncology
80. TP53 mutations and survival in patients with histologically defined Glioblastoma, IDH-wildtype
    Vincenzo Di Nunno, Lidia Gatto, Alicia Tosoni, Marta Aprile, Linda Galvani, Arianna Zappi, Maria Pia Foschini, Sofia Asioli, Giovanni Tallini, Dario de Biase et al. · 2024 · Pathology - Research and Practice
81. Identifying appropriate external control datasets in support of future glioblastoma clinical trials leveraging external data
    Rifaquat M. Rahman, Steffen Ventz, Robert Allyn Redd, Geoffrey G. Fell, Yujue Tan, Peter F. Orio, Kirk G. Tanner, Patrick Yung Wen, Lorenzo Trippa · 2025 · Neuro-Oncology
82. A Near-Infrared Fluorescent Macromolecular Dye for Precise Identification of Glioblastoma Boundaries
    Jiale Si, Li Cheng, Xin Chen, Qinghao Zhou, Yueming Xue, Yuanyuan Ji, Yansong Dong, Zhishen Ge · 2025 · Bioconjugate Chemistry
83. Three Decades of Photodynamic Therapy for Glioblastoma: A Comprehensive Scientometric Analysis
    Jiheng Zhang, Xiuwei Yan, Xin Gao, Jiahe Hu, Hongtao Zhao, Cheng-Yun Yang, Lei Xu, Yapeng Niu, Mo Geng, Nan Wang et al. · 2025 · Photodiagnosis and Photodynamic Therapy
84. Isovalerylspiramycin I Reprograms the Immunosuppressive and Temozolomide-Resistant Microenvironment by Inhibiting the Frizzled-5/Wnt/β-Catenin Pathway in Glioblastoma
    Xin Luo, Xiangyang Zhong, Tianci Zeng, Xiaodie Li, Tao Yang, Yue Qu, Yufei Lan, Sui Chen, Zhao Wang, Manqing Zhang et al. · 2025 · Research
85. Progression Patterns in Non-Contrast-Enhancing Gliomas Support Brain Tumor Responsiveness to Surgical Lesions
    Steffen Brenner, Sebastian Hartzendorf, Philip J. Vogt, Elena Maier, Nima Etminan, Erik Jung, Wolfgang Wick, Felix Sahm, Frank Winkler, Miriam Ratliff · 2022 · Pathology & Oncology Research
86. Tolerability of Repeat Awake Craniotomy: A Propensity-Score-Matched Analysis on 607 Consecutive Cases
    Hirokazu Takami, Lashmi Venkatraghavan, Tumul Chowdhury, Mark Bernstein · 2022 · World Neurosurgery
87. The HNF4A-CHPF pathway promotes proliferation and invasion through interactions with MAD1L1 in glioma
    Haitao Luo, Kai Huang, Mengqi Cheng, Xiaoyan Long, Xingen Zhu, Miaojing Wu · 2023 · Aging
88. Metabolic Syndrome and Survival in Glioblastoma Patients: Retrospective Cohort Study and Review of the Literature
    Diana Lucas, Bruno Carvalho, Rui Tuna, Paulo Linhares · 2024 · Cureus
89. Focal-to-bilateral tonic-clonic seizures and High-grade CMV-infection are poor survival predictors in Tumor-related Epilepsy Adult-type diffuse gliomas—A single-center study and literature review
    María F. De la Cerda-Vargas, Mattia Russel Pantalone, Cecilia Söderberg‐Nauclér, Rafael Medrano Guzman, Kathrine Jáuregui‐Renaud, Bárbara Nettel-Rueda, Ma. de Jesus Reynoso-Sanchez, Brenda Lopez-Quintana, Marco Antonio Rodríguez-Florido, Iris Angélica Feria-Romero et al. · 2024 · Heliyon
90. Proton pump inhibitors are detrimental to overall survival of patients with glioblastoma: Results from a nationwide real-world evidence database
    Michael P Castro, Jameson Quinn, Asher Wasserman, Alaa Awawda, Zachariah Cole, Mark A. Shapiro, Timothy Joseph Stuhlmiller, Santosh Kesari · 2024 · Neuro-Oncology Practice
91. A glutamatergic biomarker panel enables differentiating Grade 4 gliomas/astrocytomas from brain metastases
    Falko Lange, Richard Gade, Anne Einsle, Katrin Porath, Gesine Reichart, Claudia Maletzki, Björn Schneider, Christian Henker, Daniel Dubinski, Michael Linnebacher et al. · 2024 · Frontiers in Oncology
92. A viral attack on brain tumors: the potential of oncolytic virus therapy
    Kasra Mokhtarpour, Milad Akbarzadehmoallemkolaei, Nima Rezaei · 2024 · Journal of NeuroVirology
93. “Life…Gets Turned Upside-Down…” Opportunities to Improve Palliative Care for High-Grade Glioma
    Rita Caroline Crooms, Jeannys Flamine Nnemnbeng, Jennie Webster Taylor, Nathan E. Goldstein, Barbara G. Vickrey, Ksenia O. Gorbenko · 2024 · Journal of Pain and Symptom Management
94. The role of pore size and mechanical properties on the accumulation, retention and distribution of F98 glioblastoma cells in macroporous hydrogels
    Lisa Delattre, Sahar Naasri, Angéla Giraldo Solano, Hélène Therriault, Simon Bergeron-Fortier, Vaiana Moreau, Benoît Liberelle, Grégory De Crescenzo, Marc-Antoine Lauzon, Nathalie Faucheux et al. · 2024 · Biomedical Materials
95. Novel mitochondrial-related gene signature predicts prognosis and immunological status in glioma
    Yongsheng Liu, Lize Cai, Hao Wang, Lin Yao, Kai Zhang, Guangliang Chen, Youxin Zhou · 2024 · Translational Cancer Research
96. Serum CD133-Associated Proteins Identified by Machine Learning Are Connected to Neural Development, Cancer Pathways, and 12-Month Survival in Glioblastoma
    Thomas Joyce, Erdal Taşçı, Sarisha Jagasia, Jason Shephard, Shreya Chappidi, Ying Zhuge, Longze Zhang, Theresa Cooley Zgela, Mary T. Sproull, Megan A. Mackey et al. · 2024 · Cancers
97. Astaxanthin is a Novel Candidate for Glioblastoma Treatment? A Review
    Arian Rezaee, Mehrsa Radmanesh, Atena Asghari, Ahmad Nazari, Amir Abbas Shahidi, Amir Modarresi Chahardehi, Reza Arefnezhad, Tahereh Farkhondeh, Mohammad Saminin, Saeed Samarghandian · 2024 · Current Medicinal Chemistry
98. Synergistic effects of bloom helicase (BLM) inhibitor AO/854 with cisplatin in prostate cancer
    Xiaoyan Ma, Fu Tian, Yuanpin Xiao, Meng-Qiu Huang, Dan-Dan Song, Xinli Chen, Houqiang Xu · 2024 · Scientific Reports
99. Machine learning–based new classification for immune infiltration of gliomas
    Feng Yuan, Yingshuai Wang, Lei Yuan, Lei Ye, Yangchun Hu, Hongwei Cheng, Yan Li · 2024 · PLoS ONE
100. Novel Fibroblast Growth Factor Receptor 3–Fatty Acid Synthase Gene Fusion in Recurrent Epithelioid Glioblastoma Linked to Aggressive Clinical Progression
     Miguel Ángel Díaz, Felisa Vázquez-Gómez, Irene Garrido, Francisco Arias, Julia Suárez‐González, Ismael Buño, Álvaro Lassaletta · 2024 · Current Oncology